In neurodegenerative diseases such as Alzheimer's or Parkinson's, proteins accumulate in the body's cells, fold incorrectly and clump together to form larger aggregates.

LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ:LGVN) is a company that should be getting more attention from investors, and the just released quarterly results again proved that point. The ...

Learning your risk for Alzheimer’s disease through amyloid PET imaging does not appear to lead to emotional distress but may ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

Scientists know that Alzheimer’s is linked to the buildup of harmful substances in the brain called beta-amyloid plaques and ...

Meet a handful of people right here in Buffalo who are leading innovations that could become the standard treatments of ...

People react in various ways when they learn about their risk for Alzheimer’s, underscoring the importance of how such news is delivered.

Boston University CTE Center researchers are trying to diagnose CTE during life. Scientists are recruiting former football ...

The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers believe.

A new survey suggests almost 80% of American adults would want to know if they have Alzheimer's disease before they develop ...

Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says.

Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of ...